Q4 2019 Aquestive Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2019 Conference Call.
(Operator Instructions)
As a reminder, this call will be recorded. I would now like to introduce your host for today's conference, Ms. Stephanie Carrington, Westwicke Investor Relations. You may begin.
Thank you, operator. Good morning, and welcome to today's call to review Aquestive Therapeutics' Results for the Fourth Quarter and Full 2019 and Business Highlights. On today's call, I am joined by Keith Kendall, Chief Executive Officer; and John Maxwell, Chief Financial Officer, who are going to provide an overview of recent business developments and performance in the fourth quarter and full year. Additional members of the company's leadership team will be available for the Q&A. In total, we expect today's call to last approximately 60 minutes. As a reminder, our remarks today correspond with the earnings release we issued after market close yesterday.
In addition, a recording of today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |